# icosapent ethyl

NDC: 70710-1738
Generic name: icosapent ethyl
Labeler / Manufacturer: Zydus Pharmaceuticals USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20230804

FDA application: ANDA217656

## Active ingredients

- ICOSAPENT ETHYL: .5 g/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70710-1738"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70710-1738
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5910742b-c5e6-4029-9a19-97669e3808bc